In the present study, we found that miR‐222 promoted the proliferation of bladder cancer cells and attenuated CDDP‐induced cell death by regulating the PPP2R2A/Akt/mTOR axis, which indicated that miR‐222 might be a novel therapeutic target for bladder cancer. The gene discussed is MTOR; the disease is urinary bladder cancer.